HYDERABAD, India--(BUSINESS WIRE)--Cellix Bio Pharma completes the acquisition of Avaca Pharma, a formulation development company. Avaca Pharma services include discovery, formulation development, ...

The acquisition strengthens an already existing collaboration between the companies to advance clinical development of therapies across multiple drug categories. On Feb. 06, 2018, V ClinBio, a ...

Trinity College Dublin (TCD) graduate Vivienne Williams and co-founder of medical device manufacturer Cellix has won the Trinity Innovation Award. Williams’ company originated from within TCD ...

- Lead compounds for the treatment of relapsing-remitting multiple sclerosis and ulcerative colitis on target to enter clinic in 2018 - PRINCETON, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- V ClinBio Inc ...

Cellix’ Drug Discovery System Strives to Reproduce In Vivo Microenvironments Researchers working in drug discovery “have to think outside the box to insure a higher success rate for their clinical ...

Cellix Ltd. has announced that its worldwide launch of its VenaFlux™ Platform. The VenaFlux™, the first semi-automated, high throughput microfluidic cell- based assay system, measures cell adhesion to ...

The VenaFlux Platform is the first semi-automated microfluidic platform capable of executing cell rolling, binding/adhesion and migration studies under shear flow mimicking in vivo flow rates.

Cellix Biosciences Inc. ("Cellix Bio"), a development-stage pharmaceutical company, today announced successful completion of a Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and ...

An Enterprise Tech startup Cellix Bio has raised an undisclosed amount of funding across 1 rounds. The last round of funding was raised on 09 February 2018. Find the details around funding rounds, ...

As postgraduate students in the department of physics and clinical medicine at Trinity College, Dublin, Vivienne Williams and Dmitry Kashanin were working on a project to investigate microfluidics and ...